Indian authorities ordered Sun Pharma to stop producing eye-care drugs at its plant in Assam. The move escalates action against the company, India’s biggest pharmaceutical firm, after quality lapses, according to The Straits Times.
Reporting from 2 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 2 of 21604
Same format. Every time.
Continue reading — sign in or create a free account with
